Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Sees Significant Drop in Short Interest

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) saw a large decline in short interest in November. As of November 30th, there was short interest totalling 76,700 shares, a decline of 26.7% from the November 15th total of 104,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Surgical Science Sweden AB (publ) Stock Performance

Shares of SUSRF opened at $12.75 on Friday. Surgical Science Sweden AB has a 52-week low of $11.30 and a 52-week high of $14.30. The company has a 50-day simple moving average of $12.17 and a 200-day simple moving average of $12.32.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.